The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of ...

The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.

Cat anal glands probably aren’t leading anyone’s list of favorite health topics to talk about. But that doesn’t mean you can ...

UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...

It comes as Liraglutide, a drug approved to treat obesity in adults and teens, was found safe and effective for use in children ... Side effects were common among those given the drug, particularly ...